Pharmaceutical giant acquires biopharmaceutical researcher in move to diversify beyond current blockbuster drugs. Schering-Plough shares soar 14 percent; Merck dips 7.7 percent.
|
As Bush nominates new justice, Supreme Court rejects Redmond’s appeal to minimize damages in patent infringement case.
|
Vertex shares jump 20 percent; $15 million goes to BioniCare; Wilex raises $39-million Series C; NeoRx cuts its work force.
|
Struggling Schering-Plough gets go-ahead for asthma drug; the FDA approves Hepatitis B drug for Bristol-Myers Squibb; IScience Surgical gets $15 million.
|
Viagra knock-offs have hit the pharma giant where it hurts, but it's managed a rebound, allaying investor fears and outshining its rivals.
|